Hospira Inactive 10-Q2013 Q1 Quarterly report

Filed: 1 May 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: add, agreed, alert, ambulatory, American, applied, back, battery, bearing, capped, communicated, comply, constitute, Core, covenant, cumulative, deal, Derecognition, destruction, dialogue, discontinue, door, electronic, enacted, filgrastim, force, guarantee, hiring, holder, impose, indenture, infrastructure, innovation, input, labeled, legacy, LifeCare, longer, met, mid, notification, NovaQuest, older, original, Pacific, paclitaxel, Parent, PCATM, pegylated, platform, portion, premix, pretax, proposed, prosecution, prospectively, provision, receipt, recent, recently, recession, reclassified, recovery, registering, repair, retroactively, reverting, revoked, robust, SapphireTM, scope, SIP, substantial, successful, successfully, suffer, sum, suspension, Taxpayer, temporary, training, translation, unanticipated, unforeseen, variety, violative, Visakhapatnam, Zealand

Removed: achieved, alarm, arise, ASR, assessment, audible, California, classified, cleaning, competition, compound, conducted, damage, designed, develop, disposal, distributor, DURECT, effectively, enhancing, ERISA, exercisable, expiring, extend, family, finalization, fluid, focused, Fuel, Hill, hold, hour, informed, inspect, instructed, introduced, July, lag, licensing, maintenance, meropenem, Morgan, notified, observation, obsolescence, optimizing, physical, preceding, preventative, procedure, progression, promotional, proper, reach, reduced, reduction, reliability, relocation, remove, requiring, setting, significance, state, statistical, study, terminate, test, thirty, transferring, trastuzumab, unpredictable, upgrade, violation, Vishakhapatnam, wide

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Hospira similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of Chief Executive Officer Pursuant To

18 U.S.C. Section 1350

As Adopted Pursuant To

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Hospira, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2013 as filed with the Securities and Exchange Commission (the “Report”), I, F. Michael Ball, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:


(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ F. MICHAEL BALL
F. Michael Ball
Chief Executive Officer
May 1, 2013